Cnbx Pharmaceuticals Inc 's

• CNBK's Stock Performance relative to its Competitors

Corbus Pharmaceuticals Holdings Inc Share Performance -25.13% 30 Days

Corbus Pharmaceuticals Holdings Inc Profile Corbus Pharmaceuticals Holdings Inc is a biopharmaceutical company focused on the development and commercialization of innovative therapies for inflammatory and fibrotic diseases. Their business model revolves around conducting research and clinical trials to identify potential drug candidates, obtaining regulatory approvals, and subsequently commercializing these drugs to generate revenue. They aim to address unmet medical needs by creating and marketing novel treatments for diseases such as systemic sclerosis, cystic fibrosis, and other inflammatory conditions. More about Corbus Pharmaceuticals Holdings Inc 's Market Share

Inmed Pharmaceuticals Inc Share Performance -8.11% This Quarter

Inmed Pharmaceuticals Inc Profile Inmed Pharmaceuticals Inc is a biopharmaceutical company that focuses on the development of cannabinoid-based therapies for various diseases. The company's business model revolves around conducting research and development to identify novel drug candidates, conducting pre-clinical and clinical trials to test the safety and efficacy of these candidates, and seeking partnerships or collaborations with other pharmaceutical companies for the further development and commercialization of successful therapies. By leveraging advancements in cannabinoid science, Inmed Pharmaceuticals aims to provide innovative medical treatments for unmet medical needs. More about Inmed Pharmaceuticals Inc's Market Share

Novabridge Biosciences Share Performance +5.96% This Quarter

Novabridge Biosciences Profile The company develops drug candidates and conducts related research and development activities in China. More about Novabridge Biosciences's Market Share

Pharmacyte Biotech Inc Share Performance -53.09% One Year

Pharmacyte Biotech Inc Profile Pharmacyte Biotech Inc is a biotechnology company focused on developing innovative therapies for difficult-to-treat diseases, such as cancer. Their business model revolves around utilizing their proprietary technology, Cell-in-a-Box®, to encapsulate live cells that can safely and consistently deliver targeted treatments. By partnering with researchers and pharmaceutical companies, Pharmacyte aims to bring their advanced therapies to the market and improve patient outcomes. More about Pharmacyte Biotech Inc 's Market Share

Sources: Cnbx Pharmaceuticals Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Tuesday, September 15, 2026 12:00 PM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Cnbx Pharmaceuticals Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.